CPhI’s Pre-Connect Congress Agenda
-
Registrations And Networking
-
Introduction To Pre – Connect Congress
-
Inauguration And Lamp Lighting
-
Welcome Speech
-
Special Address
-
Chief Guest Address:
Discussing How Pharmaceutical And Healthcare Sectors Can Be ‘Modified’
-
Highlighting the India Investment Grid benefits – a Government initiative
-
Determining the future of the pharmaceutical industry through three Cs – Cost,
Compliance and Competition
-
Removing the road blocks between India and China to ensure more exports of drugs
from India
-
Panel Discussion:
Pharma 4.0 : Embrace Disruption To Avoid Being Disrupted
- Discussing the future of the pharmaceutical industry
- Increasing focus connecting human, data and machines
- Improving quality, productivity and lead times through interconnectivity
- Growth drivers and opportunities of investment in the pharmaceutical sector in India
Panel Members:
-
Yugal Sikri, Managing Director, RPG Life Sciences Ltd
-
Vivek Vasudev Kamath, AVP & Managing Director, MSD in India
-
Sanjay Kumar Jain, President - Amneal Pharmaceuticals, India
-
Manoj Saxena, Managing Director, Bayer Zydus Pharma
-
Dr. Sanjit Singh Lamba, Managing Director, Eisai Pharmaceuticals India Pvt Ltd
-
Networking Break
-
Presentation:
Emerging Trends In Research And Development And Its Impact On The Indian Pharma
Industry
-
Dr. Ashok Kumar FRSC, President – Centre for Research & Development,
Ipca Laboratories Ltd
-
Lunch and Networking
-
Presentation:
Challenges and opportunities in peptide drug discovery
-
Designing peptide-based scaffolds
-
Enabling technologies for enhanced analytical characterization in peptide therapeutics
discovery and development
-
Novel Technologies For Peptide Delivery
-
Presentation:
Growth Of Precision Medicines And Importance Of Patience Centricity
-
Focus on increasing diversity in clinical trials
-
Adopting trial designs, adjusting eligibility criteria and improving enrollment practices
-
Ensuring high-quality, personalized patient experience
-
Presentation:
Recent Innovations In The Medical Devices Industry In India - Getting Easier Or Tougher
- Impact of digitalization on pharmaceuticals and patient safety
-
Technological innovations in syringes for infusion sets and drug delivery
-
Meeting the regulatory expectations of various markets
-
Presentation:
Machine Learning (ML) and Artificial Intelligence (AI) in Drug Discovery
-
Utilizing AI and ML to Design Next Generation Compounds
-
Advancements in AI tools to ensure quality in manufacturing
-
Leveraging the power of AI and machine learning by utilizing high-quality big data
-
Identifying the potential to revolutionize the drug discovery and development process
-
Panel Discussion:
Shifting Focus On Complex Formulations And Portfolio Diversification Of Generics
Beyond Vanilla Oral Solids
-
Moving from conventional generics to complex generics and biosimilars
-
Focusing on higher R&D focus for niche products
-
Improved infrastructure and resources for improved surveillance
-
Understanding regulatory expectations
-
Talk Show:
Identifying The Strength Of Collaborations For Research And Development Of New
Products
-
Create new products efficiently
-
Ways to disrupt in target markets
-
Leveraging combined strengths
-
Networking Evening
